xanomeline and trospium chloride
xanomeline and trospium chloride is listed in the FDA National Drug Code directory with 8 NDC codes, marketed under brand name including Cobenfy. Available dosage forms: capsule, capsule, coated pellets, kit.
Drug Details
- Generic Name
- xanomeline and trospium chloride
- Brand Names
- Cobenfy
- Application Number
- NDA216158
- Sponsor
- Catalent Pharma Solutions, LLC
- NDC Codes
- 8
- Dosage Forms
- CAPSULE, CAPSULE, COATED PELLETS, KIT
- Routes
- ORAL
- Active Ingredients
- TROSPIUM CHLORIDE, XANOMELINE TARTRATE, XANOMELINE
Indications and Usage
1 INDICATIONS AND USAGE COBENFY is indicated for the treatment of schizophrenia in adults. COBENFY is a combination of xanomeline, a muscarinic agonist, and trospium chloride, a muscarinic antagonist, indicated for the treatment of schizophrenia in adults. ( 1 )